Kolexia
Boscher Clemence
Oncologie médicale
Centre François-Baclesse
Caen, France
29 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs post-traumatiques Trastuzumab Phosphotransferases Cyclines Hormones Récepteur ErbB-2 Kinase-4 cycline-dépendante Antinéoplasiques

Industries

MSD
2 collaboration(s)
Dernière en 2022
Lilly
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
BMC cancer   20 octobre 2022
104P HELENA: Study of HER2-low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
Abstract Book of ESMO Breast Cancer 2022, Berlin, Germany, 03-05 May 2022   01 mai 2022
Abstract P4-12-05: Benefit of multidisciplinary consultation at initiation of oral antineoplastic agents in metastatic breast cancer patients
2021 San Antonio Breast Cancer Symposium   15 février 2022
117P Pretherapeutic neutrophil-lymphocyte ratio as prognostic and predictive factors in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors
Abstract Book of the ESMO Breast Cancer Virtual Congress 202105-08 May 2021   01 mai 2021
Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors.
Cancers   16 octobre 2020
{{person.lastact6.name}}
{{person.lastact6.jour}}   {{person.lastact6.date}}
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}